COVID-19 Impact on Global Asthma Therapeutics Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Asthma Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Asthma Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Asthma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inhalation
1.4.3 Parenteral
1.4.4 Oral
1.5 Market by Application
1.5.1 Global Asthma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Coronavirus Disease 2019 (Covid-19): Asthma Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Asthma Therapeutics Industry
1.6.1.1 Asthma Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Asthma Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Asthma Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Asthma Therapeutics Market Perspective (2015-2026)
2.2 Asthma Therapeutics Growth Trends by Regions
2.2.1 Asthma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Asthma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Asthma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Asthma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Asthma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Asthma Therapeutics Players by Market Size
3.1.1 Global Top Asthma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Asthma Therapeutics Market Concentration Ratio
3.2.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2019
3.3 Asthma Therapeutics Key Players Head office and Area Served
3.4 Key Players Asthma Therapeutics Product Solution and Service
3.5 Date of Enter into Asthma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Asthma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Asthma Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Asthma Therapeutics Market Size by Application (2015-2020)
5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Asthma Therapeutics Market Size (2015-2020)
6.2 Asthma Therapeutics Key Players in North America (2019-2020)
6.3 North America Asthma Therapeutics Market Size by Type (2015-2020)
6.4 North America Asthma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Asthma Therapeutics Market Size (2015-2020)
7.2 Asthma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Asthma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Asthma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Asthma Therapeutics Market Size (2015-2020)
8.2 Asthma Therapeutics Key Players in China (2019-2020)
8.3 China Asthma Therapeutics Market Size by Type (2015-2020)
8.4 China Asthma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Asthma Therapeutics Market Size (2015-2020)
9.2 Asthma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Asthma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Asthma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Asthma Therapeutics Market Size (2015-2020)
10.2 Asthma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Asthma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Asthma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Asthma Therapeutics Market Size (2015-2020)
11.2 Asthma Therapeutics Key Players in India (2019-2020)
11.3 India Asthma Therapeutics Market Size by Type (2015-2020)
11.4 India Asthma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Asthma Therapeutics Market Size (2015-2020)
12.2 Asthma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Asthma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Asthma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview and Its Total Revenue
13.1.3 AstraZeneca Asthma Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
13.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Details
13.3.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
13.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
13.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Recent Development
13.4 GSK
13.4.1 GSK Company Details
13.4.2 GSK Business Overview and Its Total Revenue
13.4.3 GSK Asthma Therapeutics Introduction
13.4.4 GSK Revenue in Asthma Therapeutics Business (2015-2020)
13.4.5 GSK Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview and Its Total Revenue
13.5.3 Merck Asthma Therapeutics Introduction
13.5.4 Merck Revenue in Asthma Therapeutics Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Horizon Pharma
13.6.1 Horizon Pharma Company Details
13.6.2 Horizon Pharma Business Overview and Its Total Revenue
13.6.3 Horizon Pharma Asthma Therapeutics Introduction
13.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2015-2020)
13.6.5 Horizon Pharma Recent Development
13.7 Mitsubishi Tanabe Pharma
13.7.1 Mitsubishi Tanabe Pharma Company Details
13.7.2 Mitsubishi Tanabe Pharma Business Overview and Its Total Revenue
13.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
13.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2015-2020)
13.7.5 Mitsubishi Tanabe Pharma Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Asthma Therapeutics Introduction
13.8.4 Sanofi Revenue in Asthma Therapeutics Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Mundipharma
13.9.1 Mundipharma Company Details
13.9.2 Mundipharma Business Overview and Its Total Revenue
13.9.3 Mundipharma Asthma Therapeutics Introduction
13.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2015-2020)
13.9.5 Mundipharma Recent Development
13.10 Nycomed
13.10.1 Nycomed Company Details
13.10.2 Nycomed Business Overview and Its Total Revenue
13.10.3 Nycomed Asthma Therapeutics Introduction
13.10.4 Nycomed Revenue in Asthma Therapeutics Business (2015-2020)
13.10.5 Nycomed Recent Development
13.11 Kissei Pharmaceutical
10.11.1 Kissei Pharmaceutical Company Details
10.11.2 Kissei Pharmaceutical Business Overview and Its Total Revenue
10.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
10.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2015-2020)
10.11.5 Kissei Pharmaceutical Recent Development
13.12 ALK-Abello
10.12.1 ALK-Abello Company Details
10.12.2 ALK-Abello Business Overview and Its Total Revenue
10.12.3 ALK-Abello Asthma Therapeutics Introduction
10.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2015-2020)
10.12.5 ALK-Abello Recent Development
13.13 Array BioPharma
10.13.1 Array BioPharma Company Details
10.13.2 Array BioPharma Business Overview and Its Total Revenue
10.13.3 Array BioPharma Asthma Therapeutics Introduction
10.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2015-2020)
10.13.5 Array BioPharma Recent Development
13.14 SAMA Pharmaceuticals
10.14.1 SAMA Pharmaceuticals Company Details
10.14.2 SAMA Pharmaceuticals Business Overview and Its Total Revenue
10.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
10.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2015-2020)
10.14.5 SAMA Pharmaceuticals Recent Development
13.15 Whanin Pharmaceutical
10.15.1 Whanin Pharmaceutical Company Details
10.15.2 Whanin Pharmaceutical Business Overview and Its Total Revenue
10.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
10.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2015-2020)
10.15.5 Whanin Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Asthma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Asthma Therapeutics Revenue
Table 3. Ranking of Global Top Asthma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Inhalation
Table 6. Key Players of Parenteral
Table 7. Key Players of Oral
Table 8. COVID-19 Impact Global Market: (Four Asthma Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Asthma Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Asthma Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Asthma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Asthma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Asthma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Asthma Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Asthma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Asthma Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Asthma Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Asthma Therapeutics Players
Table 24. Global Asthma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Asthma Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Therapeutics as of 2019)
Table 27. Global Asthma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Asthma Therapeutics Product Solution and Service
Table 30. Date of Enter into Asthma Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Asthma Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Asthma Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Asthma Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Asthma Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Asthma Therapeutics Market Share (2019-2020)
Table 40. North America Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Asthma Therapeutics Market Share by Type (2015-2020)
Table 42. North America Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Asthma Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Asthma Therapeutics Market Share (2019-2020)
Table 46. Europe Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Asthma Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Asthma Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Asthma Therapeutics Market Share (2019-2020)
Table 52. China Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Asthma Therapeutics Market Share by Type (2015-2020)
Table 54. China Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Asthma Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Asthma Therapeutics Market Share (2019-2020)
Table 58. Japan Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Asthma Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Asthma Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Asthma Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Asthma Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Asthma Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Asthma Therapeutics Market Share (2019-2020)
Table 70. India Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Asthma Therapeutics Market Share by Type (2015-2020)
Table 72. India Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Asthma Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Asthma Therapeutics Market Share (2019-2020)
Table 76. Central & South America Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Asthma Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Asthma Therapeutics Market Share by Application (2015-2020)
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Product
Table 83. AstraZeneca Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 84. AstraZeneca Recent Development
Table 85. Boehringer Ingelheim Company Details
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 89. Boehringer Ingelheim Recent Development
Table 90. F. Hoffmann-La Roche Company Details
Table 91. F. Hoffmann-La Roche Business Overview
Table 92. F. Hoffmann-La Roche Product
Table 93. F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 94. F. Hoffmann-La Roche Recent Development
Table 95. GSK Company Details
Table 96. GSK Business Overview
Table 97. GSK Product
Table 98. GSK Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 99. GSK Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Product
Table 103. Merck Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 104. Merck Recent Development
Table 105. Horizon Pharma Company Details
Table 106. Horizon Pharma Business Overview
Table 107. Horizon Pharma Product
Table 108. Horizon Pharma Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 109. Horizon Pharma Recent Development
Table 110. Mitsubishi Tanabe Pharma Company Details
Table 111. Mitsubishi Tanabe Pharma Business Overview
Table 112. Mitsubishi Tanabe Pharma Product
Table 113. Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 114. Mitsubishi Tanabe Pharma Recent Development
Table 115. Sanofi Business Overview
Table 116. Sanofi Product
Table 117. Sanofi Company Details
Table 118. Sanofi Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 119. Sanofi Recent Development
Table 120. Mundipharma Company Details
Table 121. Mundipharma Business Overview
Table 122. Mundipharma Product
Table 123. Mundipharma Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 124. Mundipharma Recent Development
Table 125. Nycomed Company Details
Table 126. Nycomed Business Overview
Table 127. Nycomed Product
Table 128. Nycomed Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 129. Nycomed Recent Development
Table 130. Kissei Pharmaceutical Company Details
Table 131. Kissei Pharmaceutical Business Overview
Table 132. Kissei Pharmaceutical Product
Table 133. Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 134. Kissei Pharmaceutical Recent Development
Table 135. ALK-Abello Company Details
Table 136. ALK-Abello Business Overview
Table 137. ALK-Abello Product
Table 138. ALK-Abello Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 139. ALK-Abello Recent Development
Table 140. Array BioPharma Company Details
Table 141. Array BioPharma Business Overview
Table 142. Array BioPharma Product
Table 143. Array BioPharma Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 144. Array BioPharma Recent Development
Table 145. SAMA Pharmaceuticals Company Details
Table 146. SAMA Pharmaceuticals Business Overview
Table 147. SAMA Pharmaceuticals Product
Table 148. SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 149. SAMA Pharmaceuticals Recent Development
Table 150. Whanin Pharmaceutical Company Details
Table 151. Whanin Pharmaceutical Business Overview
Table 152. Whanin Pharmaceutical Product
Table 153. Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2015-2020) (Million US$)
Table 154. Whanin Pharmaceutical Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Asthma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Inhalation Features
Figure 3. Parenteral Features
Figure 4. Oral Features
Figure 5. Global Asthma Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Asthma Therapeutics Report Years Considered
Figure 9. Global Asthma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Asthma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Asthma Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Asthma Therapeutics Market Share by Players in 2019
Figure 14. Global Top Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Asthma Therapeutics Revenue in 2019
Figure 16. North America Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AstraZeneca Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 25. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Boehringer Ingelheim Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 27. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. F. Hoffmann-La Roche Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 29. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GSK Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 33. Horizon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Horizon Pharma Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 35. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Mitsubishi Tanabe Pharma Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 39. Mundipharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mundipharma Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 41. Nycomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Nycomed Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 43. Kissei Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Kissei Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 45. ALK-Abello Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. ALK-Abello Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 47. Array BioPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Array BioPharma Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 49. SAMA Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. SAMA Pharmaceuticals Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 51. Whanin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Whanin Pharmaceutical Revenue Growth Rate in Asthma Therapeutics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Montelukast Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......

Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132

According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......

Asthma Therapeutics - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114

The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028

Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146

Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......

Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028

Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144

Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......

Global Doxofylline (API) Market Research Report 2023

Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88

Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......

Global Montelukast Sodium Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164

Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs